Get started
Author

Anna C. Cole

Observed name: Anna C Cole
ORCID: 0000-0002-2832-2824
Observed ORCID: 0000-0002-2832-2824
OpenAlex ID: A5062852910
Progressively Enhancing Stemness of Adoptively Transferred T Cells with PI3Kδ Blockade Improves Metabolism and Antitumor Immunity
2023 · Guillermo O. Rangel Rivera, Connor J. Dwyer, et al. · Cancer Research · 30
PDF
Strategies for Improving CAR T Cell Persistence in Solid Tumors
2024 · Megen C. Wittling, Anna C. Cole, et al. · Cancers · 28
PDF
The yes-associated protein (YAP) is associated with resistance to anti-GD2 immunotherapy in neuroblastoma through downregulation of ST8SIA1
2023 · Adeiye A. Pilgrim, Hunter C. Jonus, et al. · OncoImmunology · 22
PDF
B cells imprint adoptively transferred CD8 + T cells with enhanced tumor immunity
2022 · Aubrey S Smith, Hannah M Knochelmann, et al. · Journal for ImmunoTherapy of Cancer · 20
Adoptively transferred Th17 cells cooperate with host B cells to achieve durable tumor immunity
2025 · Anna C. Cole, Hannah M. Knochelmann, et al. · Cancer Cell · 17
Distinct host preconditioning regimens differentially impact the antitumor potency of adoptively transferred Th17 cells
2024 · Megen C. Wittling, Hannah M. Knochelmann, et al. · Journal for ImmunoTherapy of Cancer · 4
IL15 and IL21: Better When Membrane-Tethered Together on Antitumor T Cells
2024 · Ayana T. Ruffin, Megen C. Wittling, et al. · Clinical Cancer Research · 4
PDF
The degree of T cell stemness differentially impacts the potency of adoptive cancer immunotherapy in a Lef-1 and Tcf-1 dependent manner
2023 · Guillermo O. Rangel Rivera, Connor J. Dwyer, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 3
PDF
TLR9 Agonists Potentiate Adoptive T-cell Therapy in Cancer through a B-cell–CD2 Costimulatory Axis
2026 · Ayana T. Ruffin, Vasili Toliopoulos, et al. · Cancer Research · 1
T-cell Priming by High-Avidity Neoantigens in Lymph Nodes Augments Adoptive Immunotherapy
2025 · Megen C. Wittling, Amalia M. Rivera-Reyes, et al. · Cancer Immunology Research · 1
Supplementary Data from Progressively Enhancing Stemness of Adoptively Transferred T Cells with PI3Kδ Blockade Improves Metabolism and Antitumor Immunity
2024 · Guillermo O. Rangel Rivera, Connor J. Dwyer, et al. · 1
315 Interleukin 7, 12 and 18 cooperate to induce human CD26 high CD4 T cells for potent adoptive cancer immunotherapy
2026 · Ayana T Ruffin, Michael B Ware, et al. · Journal for ImmunoTherapy of Cancer
Figure S6 from TLR9 Agonists Potentiate Adoptive T-cell Therapy in Cancer through a B-cell–CD2 Costimulatory Axis
2026 · Ayana T. Ruffin, Vasili Toliopoulos, et al.
Figure S3 from TLR9 Agonists Potentiate Adoptive T-cell Therapy in Cancer through a B-cell–CD2 Costimulatory Axis
2026 · Ayana T. Ruffin, Vasili Toliopoulos, et al.
Table S1 from TLR9 Agonists Potentiate Adoptive T-cell Therapy in Cancer through a B-cell–CD2 Costimulatory Axis
2026 · Ayana T. Ruffin, Vasili Toliopoulos, et al.
Figure S5 from TLR9 Agonists Potentiate Adoptive T-cell Therapy in Cancer through a B-cell–CD2 Costimulatory Axis
2026 · Ayana T. Ruffin, Vasili Toliopoulos, et al.
Figure S1 from TLR9 Agonists Potentiate Adoptive T-cell Therapy in Cancer through a B-cell–CD2 Costimulatory Axis
2026 · Ayana T. Ruffin, Vasili Toliopoulos, et al.
Figure S4 from TLR9 Agonists Potentiate Adoptive T-cell Therapy in Cancer through a B-cell–CD2 Costimulatory Axis
2026 · Ayana T. Ruffin, Vasili Toliopoulos, et al.
Data from TLR9 Agonists Potentiate Adoptive T-cell Therapy in Cancer through a B-cell–CD2 Costimulatory Axis
2026 · Ayana T. Ruffin, Vasili Toliopoulos, et al.
Figure S2 from TLR9 Agonists Potentiate Adoptive T-cell Therapy in Cancer through a B-cell–CD2 Costimulatory Axis
2026 · Ayana T. Ruffin, Vasili Toliopoulos, et al.
Abstract B085: Development of a Translational Manufacturing Strategy for a Novel CD4+ CD26+ mesoCAR T Cell Product for Pancreatic Ductal Adenocarcinoma Patients
2026 · Della R. Evans, Megan M. Wyatt, et al. · Cancer Research
Supplemental Table 2 from T-cell Priming by High-Avidity Neoantigens in Lymph Nodes Augments Adoptive Immunotherapy
2026 · Megen C. Wittling, Amalia M. Rivera-Reyes, et al.
Supplemental Figure 9 from T-cell Priming by High-Avidity Neoantigens in Lymph Nodes Augments Adoptive Immunotherapy
2026 · Megen C. Wittling, Amalia M. Rivera-Reyes, et al.
Supplemental Figure 7 from T-cell Priming by High-Avidity Neoantigens in Lymph Nodes Augments Adoptive Immunotherapy
2026 · Megen C. Wittling, Amalia M. Rivera-Reyes, et al.
Supplemental Table 1 from T-cell Priming by High-Avidity Neoantigens in Lymph Nodes Augments Adoptive Immunotherapy
2026 · Megen C. Wittling, Amalia M. Rivera-Reyes, et al.
Works count: 44
Citation count: 131
H-index: 5
I10-index: 5
Year
Topic
Type